A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Phio Pharmaceuticals Corp’s current trading price is -74.97% away from its 52-week high, while its distance from the 52-week low is 153.70%. The stock’s price range for this time frame has been between $0.97 and $9.79. The trading volume of the company’s shares in the Healthcare reached around 5.38 million for the day, which was evidently higher than the average daily volume of 3.06 million over the last three months.
Phio Pharmaceuticals Corp’s stock has had a tumultuous market performance.
How Financial Performance Impacts Market Capitalization
Phio Pharmaceuticals Corp (PHIO) has experienced a quarterly rise of 82.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.76M and boasts a workforce of 5 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How PHIO’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PHIO stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
PHIO Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 36.11%. However, over the past six months, we’ve seen a stronger performance of -16.10%. The price of PHIO fallen by 42.44% over the last 30 days. And in the last five days, it has surged by 20.10%.
